BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Healint announces collaboration with Saitama Medical University Hospital in Japan to verify AI diagnosis of migraine

Although there are currently 30 million chronic headache patients in Japan, the diagnosis and treatment rate of migraine among non-headache specialist...

April 28, 2023 | News

Quizartinib NDA Review for Patients with Newly Diagnosed FLT3-ITD Positive AML Extended by FDA

The FDA has extended the Prescription Drug User Fee Act (PDUFA) action date by three months to July 24, 2023 to allow additional time to review requested u...

April 21, 2023 | News

Ajinomoto Bio-Pharma Services Receives FDA Approval for High Potency Fill Line

"Receiving FDA approval on our HPAPI fill line is an exciting milestone for our company, and couldn't have happened without the hard work, hours of prepara...

April 20, 2023 | News

CPHI Japan: the rise of Chinese innovation the big macro story for APAC in 2023

“Historically, we have seen a dual strategy of focusing on China and the US for emerging innovators in China. However, a series of recent setbacks wi...

April 13, 2023 | News

Tillotts Pharma AG announces the launch of Octasa® 1600 mg tablets in Canada

The expansion of the Octasa® family in Canada with the launch of Octasa® 1600 mg represents an important step in the strategic partnership of Tillo...

April 07, 2023 | News

bitBiome and Kaken Pharmaceuticals sign joint research agreement on the discovery of drugs for infectious diseases

bitBiome, Inc. (Head office: Shinjuku-ku, Tokyo; President: Yuji Suzuki; hereafter 'bitBiome') and Kaken Pharmaceuticals (Head office: Bunkyo-ku,...

March 30, 2023 | News

Astellas and Roche Diabetes Care Japan Partner to Develop Integrated Diabetes Self-Management Solution

Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced that it has entered into an agreement ("the Agr...

March 29, 2023 | News

Aurion Biotech Receives Approval from Japan’s PMDA for New Drug Application

Aurion Biotech, whose mission is to restore vision to millions of patients with its life-changing regenerative therapies, today announced it has received r...

March 27, 2023 | News

NIPPON EXPRESS HOLDINGS Strengthens Pharmaceutical Logistics Quality System Globally

NIPPON EXPRESS HOLDINGS, INC., based in Tokyo, has compiled the NX-Pharma Global Quality Manual, applicable as of Sunday, January 1, 2023, to uni...

March 09, 2023 | News

Mallinckrodt's CELLEX® ECP System Reimbursed in Japan for cGvHD Treatment

– CELLEX ECP is now available for reimbursement in Japan for patients who are steroid-resistant or -intolerant and suffering from cGvHD &nd...

March 09, 2023 | News

Saitama Medical University International Medical Center joins TriNetX network to study rare disease treatments globally.

Saitama Medical University International Medical Center, one of Japan's leading hospitals for the treatment of oncology, cardiology, and stroke c...

March 07, 2023 | News

C2i Genomics Expands to Japan, Announces Collab with Riken Genesis

The collaboration will expand C2i’s global reach and bring MRD cancer monitoring capabilities for solid tumors to Japan C2i Genomics...

March 03, 2023 | News

Biogen Japan and Eisai Provide Update on Co-Promotion Of Multiple Sclerosis Treatments In Japan

The two companies have been jointly engaged in promotional activities for MS treatments in Japan. However, since a certain objective has been achieved rega...

March 02, 2023 | News

Olympus to Acquire Korean Gastrointestinal Stent Company Taewoong Medical Co., Ltd

Olympus Corporation (Olympus), a global medtech company committed to making people's lives healthier, safer and more fulfilling, has agreed to acquire Taew...

February 24, 2023 | News

Stay Connected